Scientific Advisory Board
Charles Cantor Ph.D.
Dr. Cantor is a founder and the Chief Scientific Officer of Sequenom, Inc., a genomics company focused on high-throughput SNP analysis and detection. Dr. Cantor is also a full professor at Boston University, where he is currently on sabbatical to focus his efforts at on SEQUENOM. Prior to joining the faculty of Boston University, he was Director of the Human Genome Center at the Department of Energy at Lawrence Berkeley Laboratory. Dr. Cantor was also the inventor of pulse field electrophoresis, for which he was elected as the youngest member to the National Academy of Sciences USA. During his science career he also has over 100 published papers.
Dudley Herschbach, Ph.D.
Dr. Herschbach is the Baird Professor of Science at Harvard University, where he received his Ph.D. in Chemical Physics in 1958. His research on the molecular dynamics of chemical reactions was awarded the Nobel Prize for Chemistry in 1986. Other honors include the National Medal of Science in 1991 and the Scientific Society Presidents' Award in 1999. He has published over 400 scientific papers dealing chiefly with chemical kinetics, molecular spectra and collision processes, theory of molecular vibrations and electronic structure, solvent-solute interactions as revealed by spectra at high pressure, catalytic reactions in drastically nonequilibrium systems, and a dimensional scaling approach to strongly correlated many-body interactions. His current research is devoted to methods of orienting molecules for studies of collision stereodynamics, means of slowing and trapping molecules in order to examine chemistry at long deBroglie wavelengths, and analysis of biomolecular motors.
Leroy Hood, M.D., Ph.D.
Dr. Hood is a founder and the Director of the Institute for Systems Biology in Seattle, Washington. While at CalTech, Dr. Hood established a worldwide reputation for his ability to anticipate the next key area of development in biotechnology. His work in the area of automating DNA sequencing led the way for the eventual sequencing of the entire human genome. Recently, Dr. Hood created the cross-disciplinary Department of Molecular Biotechnology at the University of Washington as the William Gates III Professor of Biomedical Sciences. Dr. Hood has played a role in creating numerous successful biotechnology companies, including Amgen, Inc. (NASDAQ, AMGN) and Applied Biosystems, Inc. (NYSE, ABI).
Mark Ptashne, Ph.D.
Dr. Ptashne is the Ludwig Chair of Molecular Biology at Sloan-Kettering Institute in New York City. He is a world-acknowledged founder of molecular studies of gene regulation. He has a frequently cited scientific publication record of nearly two hundred articles. Dr. Ptashne was involved in the creation of the biotechnology industry, including as a co- founder of the Genetics Institute, one of the first biotechnology companies. Genetics Institute, Inc. is now a subsidiary of Wyeth Research (NYSE: WYE). Dr. Ptashne is a recipient of the prestigious Lasker award.
P. Somasundaran, Ph.D.
Dr. Somasundaran is La von Duddleson Krumb Professor, Director Langmuir Center for Colloids & Interfaces, Director National Science Foundation Industry/University Cooperative Research Center for Advanced Studies in Novel Surfactants at Columbia University. He is a recognized authority in the areas of surface and colloid chemistry, surfactants and polymers. Dr. Somasundaran was inducted into the National Academy of Engineering in 1985, and has been elected to numerous other honorary societies, both in the U.S. and abroad. He has authored 15 books and over 600 scientific publications and patents.